Penicillin to Prevent Early Rheumatic Heart Disease in School-Aged Children
A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 9622 participants.
Also called NCT07798232
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 9,622 participants
- Sponsor
- Registry
-
NCT07798232
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Uganda
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07798232. Randomized; single masking; primary purpose prevention. Start 2027-02-01 (anticipated); primary completion 2031-07-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Penicillin to Prevent Early Rheumatic Heart Disease in School-Aged Children
- Acronym
- MEERCATS 2
- Condition
- Rheumatic Heart Disease in Children
- Intervention (Drug)
- Oral Penicillin V
- Lead sponsor
- Children's Hospital Medical Center, Cincinnati
- Collaborator
- The University of Western Australia
- Collaborator
- Uganda Heart Institute
- Collaborator
- Ochsner Health System
- Collaborator
- Murdoch Childrens Research Institute
Record details
- Record id
cardio:ct-nct07798232- Content hash
1589be89ae9d8c0496a7fc7fa0f83a42817085f96c5fa236d4d6a62b80c73971